Services provided by this Core take on various forms, in part tailored to meet the needs of the investigators who have been the users. In many instances, the service has been comprehensive and included advice on design of a targeting construct, providing selection cassettes for inclusion in the constructs, electroporation and selection of ES colonies, preparation of DMA, karyotype analysis of positive clones, and microinjection into blastocysts. Under these circumstances, the only task left to the investigator has been Southern blot analysis of DMA samples to identify targeted clones. In other instances, particularly with those in close proximity to the PI's laboratory, ES cells have been provided to the investigator for his/her own targeting. When positive clones are identified by Southern blot analysis, karyotyping and blastocyst microinjection are performed by this Core. Beyond the mechanics of gene targeting and blastocyst injection, this Core provides an additional, invaluable role--advice and assistance in the analysis of mouse phenotypes. this is largely managed by Dr. Fujiwara. The analysis of mutants requires use of specialized methods, including dissection of embryos, bleeding of embryos, hematopoietic colony assays from yolk sac, fetal liver, or peripheral blood samples, chimera analysis, and lacZ staining, in situ hybridization and histology. The experience and knowledge base of this Core has provided enormously useful advice and hands on assistance to many investigators, some who used no others services of the Core. Because the strengths became readily known in the Boston area, investigators throughout the Harvard Medical Area and elsewhere, approached this Core for guidance in evaluating their mouse knockout phenotypes. The Core has three simultaneous goals: First, the presence of this Core allows for highly efficient and successful production of gene targeted mice for members of the PI's laboratory. Second, because this Core had the appropriate expertise in both personnel and experience, it serves numerous investigators within the Harvard Medical Area and beyond. Third, this Core exports its products (largely mouse strains) to investigators elsewhere to support their own research projects and influence the field of hematology in the broadest sense.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK049216-13
Application #
7311545
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
13
Fiscal Year
2006
Total Cost
$437,014
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Vo, Linda T; Kinney, Melissa A; Liu, Xin et al. (2018) Regulation of embryonic haematopoietic multipotency by EZH1. Nature 553:506-510
Mandelbaum, Joseph; Shestopalov, Ilya A; Henderson, Rachel E et al. (2018) Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med 215:2673-2685
Yamauchi, Takuji; Masuda, Takeshi; Canver, Matthew C et al. (2018) Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. Cancer Cell 33:386-400.e5
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Cesana, Marcella; Guo, Michael H; Cacchiarelli, Davide et al. (2018) A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. Cell Stem Cell 22:575-588.e7
Blaser, Bradley W; Moore, Jessica L; Hagedorn, Elliott J et al. (2017) CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment. J Exp Med 214:1011-1027
Perlin, Julie R; Robertson, Anne L; Zon, Leonard I (2017) Efforts to enhance blood stem cell engraftment: Recent insights from zebrafish hematopoiesis. J Exp Med 214:2817-2827
Doulatov, Sergei; Vo, Linda T; Macari, Elizabeth R et al. (2017) Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci Transl Med 9:
Lessard, Samuel; Francioli, Laurent; Alfoldi, Jessica et al. (2017) Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci. Proc Natl Acad Sci U S A 114:E11257-E11266
Perlin, Julie R; Sporrij, Audrey; Zon, Leonard I (2017) Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment. J Mol Med (Berl) 95:809-819

Showing the most recent 10 out of 98 publications